News of Note—Sanofi, FluMist and more

In this week's news of note, Sanofi completed its purchase of Protein Sciences.

> Sanofi has finalized its deal for flu vaccine developer Protein Sciences. Release

> Penn State College of Medicine researchers have found that the flu vaccination rates among children were slightly lower during the last flu season after the CDC recommended against the use of AstraZeneca's nasal option FluMist. Release

> Needle-free injection company PharmaJet has announced the availability of quadrivalent flu vaccines using its technology. Release

> The startup Zipline is planning to deliver vaccines with drones in Tanzania next year. MIT Technology Review article

> Sanofi Pasteur has launched a new quadrivalent flu vaccine in Korea. Korea Biomedical Review article